NeuroOne Medical Technologies Corp
nmtc1.comWhat Do They Do?
Sells brain electrodes and ablation systems for physicians treating neurological disorders and pain, and develops spinal stimulation and brain drug-delivery devices.
10-K for FY2025, filed Dec 17, 2025We are a medical technology company focused on (i) diagnostic, ablation and deep brain stimulation technology for brain related conditions…View ↗
Evo® Cortical: Cortical or subdural electrodes are used in intracranial electroencephalography (iEEG) surgeries to monitor, record and…View ↗
Evo sEEG: Evo® sEEG Electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for…View ↗
OneRF® Brain Ablation System: Our OneRF Brain Ablation System is indicated for creation of radiofrequency lesions in nervous tissue for…View ↗
OneRF® TN Ablation System: Our OneRF® Trigeminal Nerve Ablation System is indicated for use in procedures to create radiofrequency lesions…View ↗
Drug delivery: We are also researching and developing the capability to create a new type of combination device based on our sEEG electrode…View ↗
How Do They Make Money?
It sells electrode and ablation products, with product sales counted when the goods are transferred to customers. Zimmer pays upfront for distribution licenses and may make milestone payments; fees for bundled license and development work are earned over the period the work is performed.
10-K for FY2025, filed Dec 17, 2025Revenues from product sales are recognized when control of the promised goods or services is transferred to the Company’s customers, in an…View ↗
Under the Amendment, Zimmer paid us $3.0 million for an exclusive RF Distribution License (the “RF Distribution License” and “License”) for…View ↗
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in…View ↗
$9.1M
-
10-K for FY2025, filed Dec 17, 2025
$9.1M ↗
Who Are Their Customers?
Zimmer distributes the brain electrodes and brain ablation system under an exclusive agreement. A biopharmaceutical company ordered the drug-delivery system for preclinical research.
10-K for FY2025, filed Dec 17, 2025We have received 510(k) clearance for four of our devices from the Food and Drug Administration (“FDA”), including: (i) our Evo cortical…View ↗
Based on the size and maturity of the U.S. market and our initial commercial focus, on July 20, 2020, we entered into an exclusive…View ↗
In the near term, our drug delivery system in development has already been ordered by a large biopharmaceutical company planning to test…View ↗
Do Revenues Turn Into Profits?
No. It lost $3.6M in FY2025.
10-K for FY2025, filed Dec 17, 2025
−$4.2MView ↗
10-K for FY2025, filed Dec 17, 2025
−$3.6MView ↗
10-K for FY2025, filed Dec 17, 2025
−$2.9MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q3 FY2026, filed Aug 13, 2026
−$2MView ↗
- ▲ +34% (Loss)
- vs −$1.5M in Q3 FY2025
-
Aug 13, 2026
Set fiscal 2026 product revenue guidance at $9.2 million to $10.5 million
Sources
8-K, filed Aug 13, 2026
The Company has received product orders of $11.2 million for fiscal year 2026. Recognized revenue is expected to range from $9.2 million to…View ↗
-
May 22, 2026
Announced a restatement of quarterly financial statements
Revenue and accounts receivable were overstated, and losses were understated, for the quarter and six-month period.
Sources
8-K, filed May 22, 2026
On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the…View ↗
-
Apr 30, 2026
Announced CFO retirement and named his successor
Christopher Volker was named to succeed Ronald McClurg as CFO.
Sources
8-K, filed Apr 30, 2026
On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the “Company”) of his intention to retire as the…View ↗
Growing. Revenue grew 51.1x in 4 years, from $178.1K in FY2021 to $9.1M in FY2025, about 167% a year.
Added pain ablation and drug delivery
The older business description centered on thin-film electrodes for brain recording, stimulation and ablation, plus spinal stimulation; the latest report adds a trigeminal nerve ablation system and brain drug-delivery research.
10-K for FY2022, filed Dec 22, 2022 10-K for FY2025, filed Dec 17, 2025
Who Do They Compete With?
Competes with Ad-Tech Medical Instrument, PMT, Dixi Medical, Medtronic, Monteris Medical, Clearpoint, Boston Scientific, Avanos, Stryker, Abbott, Globus, Biotronik, and Sophysa
10-K for FY2025, filed Dec 17, 2025In the market for epilepsy diagnosis, our Evo Cortical and Evo sEEG compete with Ad-Tech Medical Instrument Corporation, PMT Corporation…View ↗
Loading...
